Physician profile
Christopher A Edwards
NPI 1134296569
$42,320.43
in general payments reported to CMS, 2019-2025
10 companies · $556 in 2025
The $556 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,668 · 2020: $9,005 · 2021: $3,423 · 2022: $6,032 · 2023: $5,507 · 2024: $9,130 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $2,585 · Travel and Lodging: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $2,585.39 |
| Travel and Lodging | $607.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $41,309.91 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $430.34 | 2021-2024 | Signia |
| Baxter Healthcare | $343.90 | 2019-2020 | |
| Lilly USA, LLC | $51.32 | 2025 | Zepbound |
| Tela Bio, INC. | $49.46 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $45.87 | 2020-2022 | |
| Covidien LP | $25.18 | 2019 | |
| Heron Therapeutics, INC. | $23.17 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.42 | 2025 | |
| Novo Nordisk INC | $18.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.